4//SEC Filing
Mayer Howard 4
Accession 0001104659-22-023776
CIK 0001724344other
Filed
Feb 14, 7:00 PM ET
Accepted
Feb 15, 4:03 PM ET
Size
8.4 KB
Accession
0001104659-22-023776
Insider Transaction Report
Form 4
Mayer Howard
Director
Transactions
- Award
Stock Option (Right to Buy)
2021-07-16+12,500→ 12,500 totalExercise: $2.44Exp: 2031-07-15→ Common Stock (12,500 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2021-07-16−15,000→ 0 totalExercise: $6.44Exp: 2029-08-04→ Common Stock (15,000 underlying)
Footnotes (3)
- [F1]The option provided for vesting as follows: The shares subject to this option will vest in equal monthly installments over the three years following the date of grant, subject to the Reporting Person's continued service through each such vesting date.
- [F2]On July 16, 2021, the issuer canceled, pursuant to the issuer's option exchange program, an option for 15,000 shares of issuer's common stock granted to the Reporting Person on August 5, 2019. In exchange, the Reporting Person received a replacement option for 12,500 shares of issuer's common stock, having an exercise price of $2.44 per share.
- [F3]Seventy-three (73%) of this award will vest on July 16, 2022, and one-thirteenth of the remaining shares subject to the option will vest monthly following July 16, 2022, subject to the Reporting Person's continuing to provide service through each such date.
Documents
Issuer
Entasis Therapeutics Holdings Inc.
CIK 0001724344
Entity typeother
Related Parties
1- filerCIK 0001699610
Filing Metadata
- Form type
- 4
- Filed
- Feb 14, 7:00 PM ET
- Accepted
- Feb 15, 4:03 PM ET
- Size
- 8.4 KB